This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Berenberg Bank Remains a Hold on Roche Holding (RHHBY)
In a report released yesterday, from Berenberg Bank maintained a Hold rating on Roche Holding, with a price target of $55.00.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Currently, the analyst consensus on Roche Holding is a Hold with an average price target of $61.00.
Based on Roche Holding’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $30.32 billion and a net profit of $5.42 billion. In comparison, last year the company earned a revenue of $31.64 billion and had a net profit of $2.02 billion
Read More on RHHBY:
Disclaimer & DisclosureReport an Issue
- Xencor reports receipt of notice of termination of license agreement from Roche
- H.C. Wainwright does not see direct read from Roche miss to Olema’s OPERA-02
- Genentech announces persevERA Breast Cancer study did not meet primary endpoint
- Controversial Prasad leaving FDA, NYT reports
- Roche Chairman says diagnostics division exposed to tariffs, Reuters says
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
